Article

Reduced olfactory bulb volume and olfactory sensitivity in patients with acute major depression

Smell and Taste Clinic, Department of Otorhinolaryngology, University of Dresden Medical School, Dresden, Germany.
Neuroscience (Impact Factor: 3.33). 08/2010; 169(1):415-21. DOI: 10.1016/j.neuroscience.2010.05.012
Source: PubMed

ABSTRACT The purpose of this study was to assess olfactory function and olfactory bulb volume in patients with acute major depression in comparison to a normal population. Twenty-one patients diagnosed with acute major depressive disorder and 21 healthy controls matched by age, sex and smoking behavior participated in this study. Olfactory function was assessed in a lateralized fashion using measures of odor threshold, discrimination and identification. Olfactory bulb volumes were calculated by manual segmentation of acquired T2-weighted coronal slices according to a standardized protocol. Patients with acute major depressive disorder showed significantly lower olfactory sensitivity and smaller olfactory bulb volumes. Additionally, a significant negative correlation between olfactory bulb volume and depression scores was detected. Their results provide the first evidence, to our knowledge, of decreased olfactory bulb volume in patients with acute major depression. These results might be related to reduced neurogenesis in major depression that could be reflected also at the level of the olfactory bulb.

Download full-text

Full-text

Available from: Ilona Croy, Dec 20, 2013
0 Followers
 · 
135 Views
    • "The most prominent changes were in the OB volume, enhancement of the glomerular layer, and in the distance between mitral cell layers of both sides of the bulb during degeneration and recovery. Significant reduction in OB volume was previously reported in different MRI studies of neurological disorders such as AD, Parkinson's disease, depression and schizophrenia, which correlates with the disease progression (Turetsky et al., 2000; Thomann et al., 2009; Negoias et al., 2010; Wang et al., 2011). Increase in OB volume was shown following 3 weeks of doxycycline treatment in the present model. "
    [Show abstract] [Hide abstract]
    ABSTRACT: Manganese Enhanced MRI (MEMRI) was used to detect specific laminar changes in the olfactory bulb (OB) to follow the progression of amyloid precursor protein (APP)-induced neuronal pathology and its recovery in a reversible olfactory based Alzheimer's disease (AD) mouse model. Olfactory dysfunction is an early symptom of AD, which suggests that olfactory sensory neurons (OSNs) may be more sensitive to AD related factors than neurons in other brain areas. Previously a transgenic mouse model was established that causes degeneration of OSNs by overexpressing humanized APP (hAPP), which results in a disruption of olfactory circuitry with changes in glomerular structure. In the present work, OB volume and manganese enhancement of the glomerular layer in OB were decreased in mutant mice. Turning off APP overexpression with doxycycline produced a significant increase in manganese enhancement of the glomerular layer after only 1 week, and further recovery after 3 weeks, while treatment with Aβ antibody produced modest improvement with MRI measurements. Thus, MEMRI enables a direct tracking of laminar specific neurodegeneration through a non-invasive in vivo measurement. The use of MRI will enable assessment of the ability of different pharmacological reagents to block olfactory neuronal loss and can serve as a unique in vivo screening tool to both identify potential therapeutics and test their efficacy. Copyright © 2015. Published by Elsevier Inc.
    NeuroImage 05/2015; 118. DOI:10.1016/j.neuroimage.2015.05.045 · 6.36 Impact Factor
  • Source
    • "The described procedure was used in multiple studies focusing on OB volumetrics, with consistent results, e.g. (Buschhuter et al. 2008; Croy et al. 2013; Hummel et al. 2013a; Negoias et al. 2010). OB measurements of all data—patients and healthy group members —were performed by the same experimenter (SN) who was blind to the group category of patients and to their respective olfactory test results. "
    [Show abstract] [Hide abstract]
    ABSTRACT: The volume of the olfactory bulb (OB) is strongly reduced in patients with major depressive disorder (MDD) and this group exhibits markedly decreased olfactory function. It has been suggested that olfactory input is important for maintaining balance in limbic neurocircuits. The aim of our study was to investigate whether reduced OB volume is associated with response to therapy in MDD. Twenty-four inpatients (all women, age 21-49 years, mean 38 ± 10 years SD) with MDD and 36 healthy controls (all women, age 20-52 years, mean 36 ± 10 years SD) underwent structural MRI. OB volume was compared between responders (N = 13) and non-responders (N = 11) to psychotherapy. Retest of OB volume was performed about 6 months after the end of therapy in nine of the patients. Therapy responders exhibited no significant difference in OB volume compared to healthy controls. However, average OB volume of non-responders was 23 % smaller compared to responders (p = .0011). Furthermore, OB volume was correlated with the change of depression severity (r = .46, p = .024). Volume of the OB did not change in the course of therapy. OB volume may be a biological vulnerability factor for the occurrence and/or maintenance of depression, at least in women.
    Brain Imaging and Behavior 05/2015; DOI:10.1007/s11682-015-9400-x · 4.60 Impact Factor
  • Source
    • "This paradigm has been used to study reduced liking in depressed patients and shows mixed findings in terms of sensitivity. While some studies show reduced sensitivity to pleasant gustatory and olfactory stimuli (Berlin et al., 1998; Pause et al., 2001; Lombion-Pouthier et al., 2006; Clepce et al., 2010; Negoias et al., 2010), other studies report normal levels of identification and perception thresholds in depressed patients (Scinska et al., 2004, 2008; Swiecicki et al., 2009; Clepce et al., 2010). "
    [Show abstract] [Hide abstract]
    ABSTRACT: Anhedonia, the lack of pleasure, has been shown to be a critical feature of a range of psychiatric disorders. Yet, it is currently measured primarily through subjective self-reports and as such has been difficult to submit to rigorous scientific analysis. New insights from affective neuroscience hold considerable promise in improving our understanding of anhedonia and for providing useful objective behavioral measures to complement traditional self-report measures, potentially leading to better diagnoses and novel treatments. Here, we review the state-of-the-art of hedonia research and specifically the established mechanisms of wanting, liking, and learning. Based on this framework we propose to conceptualize anhedonia as impairments in some or all of these processes, thereby departing from the longstanding view of anhedonia as solely reduced subjective experience of pleasure. We discuss how deficits in each of the reward components can lead to different expressions, or subtypes, of anhedonia affording novel ways of measurement. Specifically, we review evidence suggesting that patients suffering from depression and schizophrenia show impairments in wanting and learning, while some aspects of conscious liking seem surprisingly intact. Furthermore, the evidence suggests that anhedonia is heterogeneous across psychiatric disorders, depending on which parts of the pleasure networks are most affected. This in turn has implications for diagnosis and treatment of anhedonia.
    Frontiers in Behavioral Neuroscience 03/2015; 9. DOI:10.3389/fnbeh.2015.00049 · 4.16 Impact Factor
Show more